Mainz Biomed NV
MYNZ0.945USD
-0.045-4.51%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
3.87MMarket Cap
LossP/E TTM
More Details of Mainz Biomed NV Company
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
Mainz Biomed NV Info
Ticker SymbolMYNZ
Company nameMainz Biomed NV
IPO dateNov 04, 2021
CEOBaechler (Guido)
Number of employees19
Security typeOrdinary Share
Fiscal year-endNov 04
AddressSirius Gutenberg Park
CityMAINZ
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryGermany
Postal code55129
Phone496131265140
Websitehttps://www.mainzbiomed.com/
Ticker SymbolMYNZ
IPO dateNov 04, 2021
CEOBaechler (Guido)
Company Executives of Mainz Biomed NV
Name
Name/Position
Position
Shareholding
Change
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
20.06K
+1250.00%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
17.77K
-151.00%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+2331.00%
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
2.20K
--
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
20.06K
+1250.00%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
17.77K
-151.00%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+2331.00%
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
2.20K
--
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Fri, Feb 6
Updated: Fri, Feb 6
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Donahue (Kevin Michael)
7.56%
Armistice Capital LLC
4.35%
UBS Financial Services, Inc.
0.60%
Dauntless Investment Group, LLC
0.56%
Fur Wiederaufbau (Kredianstalt)
0.26%
Other
86.67%
Shareholders
Shareholders
Proportion
Donahue (Kevin Michael)
7.56%
Armistice Capital LLC
4.35%
UBS Financial Services, Inc.
0.60%
Dauntless Investment Group, LLC
0.56%
Fur Wiederaufbau (Kredianstalt)
0.26%
Other
86.67%
Shareholder Types
Shareholders
Proportion
Individual Investor
8.38%
Hedge Fund
4.35%
Investment Advisor
1.48%
Other
85.78%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
31
529.42K
5.84%
+130.09K
2025Q3
32
386.03K
7.13%
+144.51K
2025Q2
35
323.69K
7.07%
-4.46K
2025Q1
40
350.55K
9.90%
-3.02K
2024Q4
40
356.23K
16.03%
+257.88K
2024Q3
37
115.45K
5.70%
+19.26K
2024Q2
34
120.95K
9.96%
+24.53K
2024Q1
36
122.04K
10.26%
+25.33K
2023Q4
27
96.56K
23.08%
+9.46K
2023Q3
22
91.42K
24.64%
+4.27K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Armistice Capital LLC
394.52K
4.35%
+109.52K
+38.43%
Sep 30, 2025
UBS Financial Services, Inc.
7.00K
0.08%
-2.81K
-28.64%
Sep 30, 2025
Dauntless Investment Group, LLC
51.00K
0.56%
+1.00K
+2.00%
Sep 30, 2025
Fur Wiederaufbau (Kredianstalt)
23.20K
0.26%
-7.74K
-25.00%
Sep 30, 2024
Baechler (Guido)
20.06K
0.22%
+1.25K
+6.65%
Mar 21, 2025
Hekland (Hans)
17.77K
0.2%
-151.00
-0.84%
Mar 21, 2025
Journey Advisory Group, LLC
15.00K
0.17%
--
--
Sep 30, 2025
Steward Partners Investment Advisory, LLC
10.00K
0.11%
--
--
Sep 30, 2025
Caragol (William J)
7.90K
0.09%
+2.58K
+48.56%
Mar 21, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Nov 29, 2024
Merger
40→1
Nov 29, 2024
Merger
40→1
Nov 29, 2024
Merger
40→1
Nov 29, 2024
Merger
40→1
Date
Ex-dividend Date
Type
Ratio
Nov 29, 2024
Merger
40→1
Nov 29, 2024
Merger
40→1
Nov 29, 2024
Merger
40→1
Nov 29, 2024
Merger
40→1
